jRCT1030220517
Untitled Trial
Japanese Patient and Physician Preferences for Systemic Therapy Combined with Transarterial Chemoembolization for Hepatocellular Carcinoma: A Discrete Choice Experiment (SANGO HCC)
AstraZeneca K.K.·Japan Registry Clinical TrialRecruitment Completed
Study focus
- Disease/Condition
- Hepatocellular carcinoma
- Study type
- Observational
Sponsor & location
- Primary sponsor
- AstraZeneca K.K.
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Malignant neoplasm: HepatoblastomaMalignant neoplasm: Liver cell carcinomaMalignant neoplasm: Other specified carcinomas of liverMalignant neoplasm: Liver, unspecifiedMalignant neoplasm: Hepatic flexure
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCT1030220517
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCT1030220517 through Pure Global AI's free database. This phase not specified trial is sponsored by AstraZeneca K.K. and is currently Recruitment Completed. The study focuses on Hepatocellular carcinoma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.